Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,877
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis

Manuel KussmannDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Matthias KarerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Markus ObermuellerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Katy SchmidtCenter for Anatomy and Cell Biology, Division of Cell and Developmental BiologyMedical University of ViennaViennaAustria
,
Wolfgang BarouschDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Doris MoserDepartment of Cranio-Maxillofacial and Oral SurgeryMedical University of ViennaViennaAustria
,
Marion NehrDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Michael RamharterDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria;Department of Tropical Medicine; Bernhard Nocht Institute for Tropical Medicine & I. Dep. Of MedicineUniversity Medical Center Hamburg-EppendorfHamburgGermany
,
Wolfgang PoepplDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria;Military Medical Cluster EastAustrian Armed ForcesViennaAustria
,
Athanasios MakristathisDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Stefan WinklerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Florian ThalhammerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Heinz BurgmannDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
&
Heimo LaglerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustriaCorrespondence[email protected]
 show all
Pages 1-10 | Received 20 Aug 2018, Accepted 11 Nov 2018, Published online: 05 Dec 2018

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lorenzo Volpicelli, Mario Venditti & Alessandra Oliva. (2023) Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin. Expert Review of Anti-infective Therapy 21:4, pages 329-341.
Read now
Milo Gatti, Massimo Andreoni, Federico Pea & Pierluigi Viale. (2021) Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs. Drug Design, Development and Therapy 15, pages 3349-3378.
Read now
Vanessa Silva, Carla Miranda, Mário Bezerra, H. Sofia Antão, João Guimarães, Justina Prada, Isabel Pires, Luís Maltez, José E. Pereira, José L. Capelo, Gilberto Igrejas & Patrícia Poeta. (2021) Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection. Journal of Chemotherapy 33:7, pages 469-475.
Read now
Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, Francesca Raumer, Eugenia Di Meco, Maria Cristina Moioli, Federica Tordato, Paola Morelli, Federica Borghi, Marco Rizzi, Evelyn Van Hauwermeiren, Francesco Castelli, Guglielmo Migliorino, Barbara Menzaghi, Giuliano Rizzardini, Annalisa Saracino, Antonio Cascio, Massimo Puoti, Antonella d’Arminio Monforte & Giulia Marchetti. (2020) Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). Expert Review of Anti-infective Therapy 18:12, pages 1271-1279.
Read now

Articles from other publishers (43)

Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve & Michael J. Rybak. (2024) Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious Diseases and Therapy 13:3, pages 565-579.
Crossref
Yuina Tsujino, Eiki Ogawa & Kenta Ito. (2023) Thymidine‐dependent small‐colony variants of Staphylococcus aureus isolated from infective endocarditis in a postlung transplant patient . Transplant Infectious Disease 26:1.
Crossref
Javier Gonzalez Cepeda, Fernando Lázaro Perona, Ivan Bloise Sanchez, Juana Cacho Calvo, Alicia Rico & Belen Loeches. (2024) Case report: Prosthetic aortic valve endocarditis due to Staphylococcus epidermidis with acquired resistance in the walK gene. Diagnostic Microbiology and Infectious Disease 108:2, pages 116132.
Crossref
Si Liu, Hongbin Chen, Fangjie Xu, Fengning Chen, Yuyao Yin, Xiaoyang Zhang, Shangyu Tu & Hui Wang. (2024) Unravelling staphylococcal small-colony variants in cardiac implantable electronic device infections: clinical characteristics, management, and genomic insights. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Alessandra Oliva, Francesco Cogliati Dezza, Francesca Cancelli, Ambrogio Curtolo, Antonio Falletta, Lorenzo Volpicelli & Mario Venditti. (2023) New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended. Journal of Clinical Medicine 12:24, pages 7693.
Crossref
Maria Tsalidou, Theodouli Stergiopoulou, Ioannis Bostanitis, Christina Nikaki, Kalypso Skoumpa, Theofani Koutsoukou & Paraskevi Papaioannidou. (2023) Surveillance of Antimicrobial Resistance and Multidrug Resistance Prevalence of Clinical Isolates in a Regional Hospital in Northern Greece. Antibiotics 12:11, pages 1595.
Crossref
Polina V. Grebenkina, Sergey A. Selkov, Lyudmila А. Kraeva & Dmitriy I. Sokolov. (2023) Crosstalk between ESKAPE bacteria and NK cells: mutual regulation and role in developing reproductive tract pathologies. Russian Journal of Infection and Immunity 13:4, pages 609-626.
Crossref
Nikki N. Tran, Taylor Morrisette, Sarah C. J. Jorgensen, José M. Orench‐Benvenutti & Razieh Kebriaei. (2023) Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:8, pages 816-832.
Crossref
Vladimir Gostev, Olga Kalinogorskaya, Julia Sopova, Ofelia Sulian, Polina Chulkova, Maria Velizhanina, Irina Tsvetkova, Irina Ageevets, Vladimir Ageevets & Sergey Sidorenko. (2023) Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance. Antibiotics 12:5, pages 928.
Crossref
T. Fazili, E. Bansal, D. Garner, M. Gomez & N. Stornelli. (2023) Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review. International Journal of Antimicrobial Agents 61:4, pages 106749.
Crossref
Wei Wang, Hui Li, Changwei Wang, Fengqin Li, Yinping Dong & Jing Xiao. (2023) Antimicrobial Resistance, Virulence, and Genetic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered from Ready-to-Eat (RTE) Food in China: A New Challenge for Food Safety. Zoonoses 3:1.
Crossref
Bilal Aslam, Moeed Ahmad, Muhammad Usama Tariq, Saima Muzammil, Abu Baker Siddique, Mohsin Khurshid, Aqsa Shahid, Muhammad Hidayat Rasool, Tamoor Hamid Chaudhry, Afreenish Amir, Muhammad Salman & Zulqarnain Baloch. 2023. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources 1 37 .
I.W. FongI. W. Fong. 2023. New Antimicrobials: For the Present and the Future. New Antimicrobials: For the Present and the Future 59 75 .
Rutan Zhang, Hari Polenakovik, Ismael A Barreras Beltran, Adam Waalkes, Stephen J Salipante, Libin Xu & Brian J Werth. (2022) Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization . Clinical Infectious Diseases 75:9, pages 1641-1644.
Crossref
Emma van Groesen, Paolo Innocenti & Nathaniel I. Martin. (2022) Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022. ACS Infectious Diseases 8:8, pages 1381-1407.
Crossref
Pier Giorgio Cojutti, Sara Tedeschi, Milo Gatti, Eleonora Zamparini, Marianna Meschiari, Paola Della Siega, Maria Mazzitelli, Laura Soavi, Raffaella Binazzi, Elke Maria Erne, Marco Rizzi, Anna Maria Cattelan, Carlo Tascini, Cristina Mussini, Pierluigi Viale & Federico Pea. (2022) Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring. Antibiotics 11:8, pages 996.
Crossref
Kyle C. Molina, Matthew A. Miller, Scott W. Mueller, Edward T. Van Matre, Martin Krsak & Tyree H. Kiser. (2021) Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clinical Pharmacokinetics 61:3, pages 363-374.
Crossref
Eleonora Riccobono, Tommaso Giani, Giulia Baldi, Sophie Arcangeli, Alberto Antonelli, Valeria Tellone, Alessandra Del Vecchio, Alessandra Capezzone De Joannon & Gian Maria Rossolini. (2022) Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017–2018), and on clonal distribution of MRSA. International Journal of Antimicrobial Agents 59:2, pages 106503.
Crossref
Henan Guo, Yucui Tong, Junhao Cheng, Zaheer Abbas, Zhongxuan Li, Junyong Wang, Yichen Zhou, Dayong Si & Rijun Zhang. (2022) Biofilm and Small Colony Variants—An Update on Staphylococcus aureus Strategies toward Drug Resistance. International Journal of Molecular Sciences 23:3, pages 1241.
Crossref
Ivana Ćirković & Milena Švabić-Vlahović. (2022) Nosocomial antibiotic strain resistance. Galenika Medical Journal 1:3, pages 60-68.
Crossref
Atamjit Singh, Kirandeep Kaur, Pallvi Mohana, Avneet Kaur, Komalpreet Kaur, Shilpa Heer, Saroj Arora, Neena Bedi & Preet Mohinder Singh Bedi. 2021. Insights Into Drug Resistance in Staphylococcus aureus. Insights Into Drug Resistance in Staphylococcus aureus.
Benjamin Jacob, Oliwia Makarewicz, Anita Hartung, Steffen Brodt, Eric Roehner & Georg Matziolis. (2021) In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus. Scientific Reports 11:1.
Crossref
Alessandra Oliva, Stefania Stefani, Mario Venditti & Enea Gino Di Domenico. (2021) Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin. Frontiers in Microbiology 12.
Crossref
Elias Dahdouh, Beatriz Díaz-Pollán, Iker Falces-Romero, Jesús Mingorance & Rosa Gómez-Gil. (2021) Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases 40:9, pages 2029-2032.
Crossref
Juan Chen, Huyue Zhou, Jingbin Huang, Rong Zhang & Xiancai Rao. (2021) Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics. Journal of Advanced Research 31, pages 165-175.
Crossref
Huan Zhang, Weiying Zhou, Jin Wang & Yun Cai. (2021) Efficacy and safety of oritavancin for the treatment of acute bacterial skin and skin-structure infections: a systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 25, pages 380-389.
Crossref
Alejandra Asenjo, Jesús Oteo-Iglesias & Juan-Ignacio Alós. (2021) What's new in mechanisms of antibiotic resistance in bacteria of clinical origin?. Enfermedades infecciosas y microbiologia clinica (English ed.) 39:6, pages 291-299.
Crossref
Alejandra Asenjo, Jesús Oteo-Iglesias & Juan-Ignacio Alós. (2021) What's new in mechanisms of antibiotic resistance in bacteria of clinical origin?. Enfermedades Infecciosas y Microbiología Clínica 39:6, pages 291-299.
Crossref
Brian J. Werth, Nathaniel K. Ashford, Kelsi Penewit, Adam Waalkes, Elizabeth A. Holmes, Dylan H. Ross, Tianwei Shen, Kelly M. Hines, Stephen J. Salipante & Libin Xu. (2021) Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 27:6, pages 910.e1-910.e8.
Crossref
Christopher F. Rowley & Audrey Li. 2021. The Opioid Epidemic and Infectious Diseases. The Opioid Epidemic and Infectious Diseases 125 160 .
Yas Sanaiha, Robert Lyons & Peyman Benharash. (2020) Infective endocarditis in intravenous drug users. Trends in Cardiovascular Medicine 30:8, pages 491-497.
Crossref
Temi Lampejo. (2020) Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review. International Journal of Antimicrobial Agents 56:3, pages 106072.
Crossref
Geren Thomas, Andrés F. Henao-Martínez, Carlos Franco-Paredes & Daniel B. Chastain. (2020) Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review. International Journal of Antimicrobial Agents 56:3, pages 106069.
Crossref
Asher Schranz & Joshua A. Barocas. (2020) Infective Endocarditis in Persons Who Use Drugs. Infectious Disease Clinics of North America 34:3, pages 479-493.
Crossref
David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Scott A. Beatson, David L. Paterson & Mark J. Walker. (2020) Antimicrobial Resistance in ESKAPE Pathogens. Clinical Microbiology Reviews 33:3.
Crossref
Lorena Tuchscherr, Bettina Löffler & Richard A. Proctor. (2020) Persistence of Staphylococcus aureus: Multiple Metabolic Pathways Impact the Expression of Virulence Factors in Small-Colony Variants (SCVs). Frontiers in Microbiology 11.
Crossref
Martin Krsak, Taylor Morrisette, Matthew Miller, Kyle Molina, Misha Huang, Laura Damioli, Larissa Pisney, Megan Wong & Eric Poeschla. (2020) Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:5, pages 469-478.
Crossref
Aaron Hakim, Hannan Braun, David Thornton & Judith Strymish. (2020) Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report. International Journal of Infectious Diseases 91, pages 202-205.
Crossref
Vincenzo Di Pilato, Federica Ceccherini, Samanta Sennati, Federico D'Agostino, Fabio Arena, Noemi D'Atanasio, Francesco Paolo Di Giorgio, Serena Tongiani, Lucia Pallecchi & Gian Maria Rossolini. (2020) In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times. Diagnostic Microbiology and Infectious Disease 96:2, pages 114901.
Crossref
Richard R. Watkins, Marisa Holubar & Michael Z. David. (2019) Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents . Antimicrobial Agents and Chemotherapy 63:12.
Crossref
Jessica Howard-Anderson, Stephanie M Pouch, Mary Elizabeth Sexton, Aneesh K Mehta, Andrew L Smith, George M LyonIIIIII & Rachel Friedman-Moraco. (2019) Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report. Open Forum Infectious Diseases 6:9.
Crossref
Fabian Grein, Tanja Schneider & Hans-Georg Sahl. (2019) Docking on Lipid II—A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides. Journal of Molecular Biology 431:18, pages 3520-3530.
Crossref
. (2019) Dalbavancin. Reactions Weekly 1734:1, pages 170-170.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.